ResMed Inc (RMD)
183.52
-0.26
(-0.14%)
USD |
NYSE |
Apr 25, 16:00
198.51
+14.99
(+8.17%)
After-Hours: 20:00
ResMed Free Cash Flow (Quarterly): 248.27M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 248.27M |
| September 30, 2023 | 245.42M |
| June 30, 2023 | 198.70M |
| March 31, 2023 | 251.34M |
| December 31, 2022 | 96.97M |
| September 30, 2022 | 12.29M |
| June 30, 2022 | 47.09M |
| March 31, 2022 | 65.28M |
| December 31, 2021 | 180.19M |
| September 30, 2021 | -97.45M |
| June 30, 2021 | 195.65M |
| March 31, 2021 | 167.13M |
| December 31, 2020 | 131.84M |
| September 30, 2020 | 125.26M |
| June 30, 2020 | 309.08M |
| March 31, 2020 | 207.59M |
| December 31, 2019 | 42.03M |
| September 30, 2019 | 137.62M |
| June 30, 2019 | 117.54M |
| March 31, 2019 | 122.65M |
| December 31, 2018 | 109.00M |
| September 30, 2018 | 32.51M |
| June 30, 2018 | 109.66M |
| March 31, 2018 | 134.00M |
| December 31, 2017 | 114.20M |
| Date | Value |
|---|---|
| September 30, 2017 | 75.71M |
| June 30, 2017 | 119.67M |
| March 31, 2017 | 50.61M |
| December 31, 2016 | 103.08M |
| September 30, 2016 | 69.21M |
| June 30, 2016 | 126.16M |
| March 31, 2016 | 109.56M |
| December 31, 2015 | 138.60M |
| September 30, 2015 | 105.78M |
| June 30, 2015 | 85.13M |
| March 31, 2015 | 78.05M |
| December 31, 2014 | 84.56M |
| September 30, 2014 | 63.49M |
| June 30, 2014 | 94.33M |
| March 31, 2014 | 80.96M |
| December 31, 2013 | 62.83M |
| September 30, 2013 | 71.99M |
| June 30, 2013 | 105.57M |
| March 31, 2013 | 86.01M |
| December 31, 2012 | 76.08M |
| September 30, 2012 | 63.39M |
| June 30, 2012 | 83.44M |
| March 31, 2012 | 74.42M |
| December 31, 2011 | 96.23M |
| September 30, 2011 | 67.96M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-97.45M
Minimum
Sep 2021
309.08M
Maximum
Jun 2020
141.15M
Average
137.62M
Median
Sep 2019
Free Cash Flow (Quarterly) Benchmarks
| Stryker Corp | 1.383B |
| Boston Scientific Corp | 690.00M |
| Integer Holdings Corp | 18.53M |
| Haemonetics Corp | -22.83M |
| Insulet Corp | 13.60M |